Melanie Bolch Isbill
Directeur/Bestuurslid bij The Michael J. Fox Foundation for Parkinson's Research
Profiel
Melanie Bolch Isbill is currently the Director at The Michael J.
Fox Foundation for Parkinson's Research since 2021.
He completed his undergraduate degree from The Wharton School of the University of Pennsylvania.
Actieve functies van Melanie Bolch Isbill
| Bedrijven | Functie | Begin |
|---|---|---|
The Michael J. Fox Foundation for Parkinson's Research
 The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Directeur/Bestuurslid | 11-03-2021 |
Opleiding van Melanie Bolch Isbill
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Commercial Services |
